MDACC

Running trials

• Recruiting

  Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

  NCT07484022· Phase 1· Source

• Active, not recruiting

  A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer

  NCT05608044· Phase 2· Source

• Recruiting

  Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

  NCT05245500· Phase 1· Source

• Recruiting

  A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

  NCT04988555· Phase 1/2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute lymphoblastic leukaemia1 recruiting
• Acute myeloid leukemia1 recruiting
• Bladder cancer1 recruiting
• Childhood cancers1 recruiting
• Lung cancer1 recruiting
• Mesothelioma1 recruiting
• Multiple myeloma1 recruiting
• Myelodysplastic syndromes1 recruiting
• Pancreatic cancer1 recruiting
• Sarcoma1 recruiting

Researchers

No researcher is linked here yet.